The Week Many Have Been Waiting For

Sep 26, 2016, 10:18 ET from FN Media Group, LLC

MIAMI, September 26, 2016 /PRNewswire/ -- Briefing: This is the week many have been waiting for.  With markets approaching new highs, the Presidential debates will be underway tonight.  Fiscal policy and global trade will surely be among the topics discussed. This has some curious to see what the market reaction will be.  The Fed continues to remain unchanged on rates while many stocks have favorably reacted over the last few weeks of the summer.  Now, heading into the new week, there are several stocks to watch after having seen active trading sessions to close out last week.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) has been climbing in price since last Wednesday with volume levels building at an above average pace.  This biotechnology company has been making key announcements on its presentation/conference circuit that it has been on for the better part of the last month.  In its most recent announcement the company stated that its Chief Executive Officer, Charles Rowland, will participate in a Fireside Chat at the Leerink Partners Roundtable Series this coming Wednesday morning at 11:05AM EST.  Shares of AUPH are up roughly 13% during this period.

StrikeForce Technologies, Inc. (OTC: SFOR) has also realized a significant increase in price and volume over the last few weeks. Since announcing its second quarter financials about a month ago, shares of SFOR have climbed as high as $0.0138 as of Friday's session. The recent breach of accounts has brought more light to cyber security and StrikeForce Technologies' business is based around helping to prevent online identity theft and data security breaches for consumers, corporations, and government agencies. Since September 15, shares of StrikeForce are up more than 220%.

IDDRIVEN INC (OTC: IDDR) (OTCQB: IDDR) has also seen a response to the recent string of data and security breaches.  As an access management and identity governance, IDDR is focused on preventing data breaches both internally from employees as well as externally via outside impediments. Since hitting lows of $0.051 in early September, shares of IDdriven have increased by as much as 292% throughout the month and closed at $0.1634; still up over 200% from earlier lows.

This morning, IDDR announced that it has hired Neil Kleinman as the North American Sales Manager. Arend Verweij, CEO of IDdriven, Inc. states, "Mr. Kleinman is a warm welcomed addition to our team and we fully expect that his efforts will help spearhead our sales strategy in North America."

Onconova Therapeutics, Inc. (NASDAQ: ONTX) announced today that it had received the End-of-Phase 2 meeting minutes from the FDA for the combination of oral rigosertib with azacitidine for the treatment of patients with higher-risk myelodysplastic syndrome. With this, Onconova has stated that it will design a randomized, controlled Phase 3 clinical trial comparing the combination of oral rigosertib plus azacitidine to azacitidine plus placebo in 1st-line HR-MDS patients. Since September 19, shares of ONTX have seen increases in both average volume and relative price.  Shares have jumped as much as 25% during this period.

"We are encouraged that our interactions with FDA resulted in agreement on the patient population to be evaluated and the selection of overall response as the primary endpoint in this pivotal trial," stated Steven Fruchtman, M.D., Chief Medical Officer of Onconova. 

DISCLAIMER: is Source of all content listed above.  FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with or any company mentioned herein.  The commentary, views and opinions expressed in this release by are solely those of and are not shared by and do not reflect in any manner the views or opinions of FNM.  The companies that are discussed herein may or may not have approved the statements made in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM was not compensated by any public company mentioned herein to disseminate this press release.


This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information: Company:  FN Media Group, LLC Contact e-mail: U.S. Phone: +1(954)345-0611 URL:

SOURCE FN Media Group, LLC